Patents Assigned to 23andMe, Inc.
  • Patent number: 11515047
    Abstract: A method, software, database and system for attribute partner identification and social network based attribute analysis are presented in which attribute profiles associated with individuals can be compared and potential partners identified. Connections can be formed within social networks based on analysis of genetic and non-genetic data. Degrees of attribute separation (genetic and non-genetic) can be utilized to analyze relationships and to identify individuals who might benefit from being connected.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: November 29, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11514627
    Abstract: The disclosed embodiments concern methods, apparatus, systems and computer program products for determining and displaying pedigrees based on IBD data. Some implementations use a probabilistic relationship model to obtain various likelihoods of various potential relationships based on pairwise IBD data and pairwise age data. Some implementations build large pedigrees by combining smaller pedigrees. Some implementations display pedigree graphs with various features that are informative and easy to understand.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: November 29, 2022
    Assignee: 23andMe, Inc.
    Inventors: Ethan M. Jewett, Andrew C. Seaman, Kimberly F. McManus, William A. Freyman, Cordell T. Blakkan, Adam Auton, Joanna L. Mountain, Susan M. Furest, Rachel E. Lopatin, Hang Xu, Hilary M. Vance
  • Patent number: 11515046
    Abstract: A method, software, database and system for determining an optimal treatment for an illness in an individual and for determining the impact (e.g., side effects and intended benefits) of the treatment in the individual are presented in which an attribute profile of the individual containing genetic and non-genetic attributes is compared against a database containing combinations genetic and non-genetic attributes that are statistically associated with successful treatment of the illness in other individuals.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: November 29, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew A. Kenedy, Charles A. Eldering
  • Patent number: 11514085
    Abstract: An embodiment may involve storing, by a computing device and in a database, a set of pangenetic attributes of a set of individuals, wherein the pangenetic attributes of the set are respectively and statistically associated with products; based on the statistical associations between the pangenetic attributes and the products, determining, by the computing device, product recommendations for a second set of individuals; receiving, by the computing device and from the second set of individuals, a plurality of measures of satisfaction with the product recommendations; based on the plurality of measures of satisfaction, learning, by the computing device, an association between a subset of the pangenetic attributes and a particular product; and storing, by the computing device and in the database, the learned association, wherein the learned association provides a basis for subsequent recommendations of the particular product when a subsequent individual exhibits the subset of the pangenetic attributes.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: November 29, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11508461
    Abstract: Determining relative relationships of people who share a common ancestor within at least a threshold number of generations includes: receiving recombinable deoxyribonucleic acid (DNA) sequence information of a first user and recombinable DNA sequence information of a plurality of users; processing, using one or more computer processors, the recombinable DNA sequence information of the plurality of users in parallel; determining, based at least in part on a result of processing the recombinable DNA information of the plurality of users in parallel, a predicted degree of relationship between the first user and a user among the plurality of users, the predicted degree of relative relationship corresponding to a number of generations within which the first user and the second user share a common ancestor.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: November 22, 2022
    Assignee: 23andMe, Inc.
    Inventors: Lawrence Hon, Serge Saxonov, Brian Thomas Naughton, Joanna Louise Mountain, Anne Wojcicki, Linda Avey
  • Patent number: 11495360
    Abstract: A method, software, database and system for attribute partner identification and social network based attribute analysis are presented in which attribute profiles associated with individuals can be compared and potential partners identified. Connections can be formed within social networks based on analysis of genetic and non-genetic data. Degrees of attribute separation (genetic and non-genetic) can be utilized to analyze relationships and to identify individuals who might benefit from being connected.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: November 8, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11482340
    Abstract: A method, software, database, and system in which a query attribute is used as the basis for accessing stored attribute combinations and their frequencies of occurrence for individuals; and tabulating, based on frequencies of occurrence, those attribute combinations that are most likely to co-occur with the query attribute.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: October 25, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11468971
    Abstract: Inferring a characteristic of an individual is disclosed. An indication that a first user and a second user have at least one shared chromosomal segment is received. Information about the second user is obtained. A characteristic of the first user is inferred based at least in part on the information about the second user.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: October 11, 2022
    Assignee: 23andMe, Inc.
    Inventors: John Michael Macpherson, Brian Thomas Naughton, Joanna Louise Mountain
  • Patent number: 11348691
    Abstract: A method, software, database and system for attribute partner identification and social network based attribute analysis are presented in which attribute profiles associated with individuals can be compared and potential partners identified. Connections can be formed within social networks based on analysis of genetic and non-genetic data. Degrees of attribute separation (genetic and non-genetic) can be utilized to analyze relationships and to identify individuals who might benefit from being connected.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: May 31, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11348692
    Abstract: A method, software, database and system for attribute partner identification and social network based attribute analysis are presented in which attribute profiles associated with individuals can be compared and potential partners identified. Connections can be formed within social networks based on analysis of genetic and non-genetic data. Degrees of attribute separation (genetic and non-genetic) can be utilized to analyze relationships and to identify individuals who might benefit from being connected.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: May 31, 2022
    Assignee: 23andMe, Inc.
    Inventors: Andrew Alexander Kenedy, Charles Anthony Eldering
  • Patent number: 11322227
    Abstract: Determining relative relationships of people who share a common ancestor within at least a threshold number of generations includes: receiving recombinable deoxyribonucleic acid (DNA) sequence information of a first user and recombinable DNA sequence information of a plurality of users; processing, using one or more computer processors, the recombinable DNA sequence information of the plurality of users in parallel; determining, based at least in part on a result of processing the recombinable DNA information of the plurality of users in parallel, a predicted degree of relationship between the first user and a user among the plurality of users, the predicted degree of relative relationship corresponding to a number of generations within which the first user and the second user share a common ancestor.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: May 3, 2022
    Assignee: 23andMe, Inc.
    Inventors: Lawrence Hon, Serge Saxonov, Brian Thomas Naughton, Joanna Louise Mountain, Anne Wojcicki, Linda Avey
  • Publication number: 20220106395
    Abstract: The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP) and fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Compositions comprising such binding proteins and methods of making and using such binding proteins are also provided.
    Type: Application
    Filed: September 27, 2021
    Publication date: April 7, 2022
    Applicant: 23andMe, Inc.
    Inventors: Davide Foletti, Erik Karrer, Germaine Fuh-KELLY, Kristie Ibarra, Quan Zheng, Yao-ming Huang, Lindsay Deis, Christine Wolak, Dominic Samuel Berns
  • Publication number: 20210371521
    Abstract: The present disclosure provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human CD200R1 receptor protein (hu-CD200R1) and are capable of decreasing, inhibiting, and/or fully-blocking immune regulatory effects mediated by hu-CD200R1. The present disclosure also provides methods of using the antibodies (and compositions thereof) to treat diseases and conditions responsive to decreasing, inhibiting and/or blocking immune regulatory function or activity mediated by CD200 binding to CD200R1.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 2, 2021
    Applicant: 23andMe, Inc.
    Inventors: Yu CHEN, Jilean Beth FENAUX, Germaine FUH-KELLY, Yao-Ming HUANG, Wei-Jen CHUNG, Erik Edward KARRER, Cecilia LAY, Steven J. PITTS, Louise SCHARF
  • Patent number: 11170873
    Abstract: Displaying a comparison of genotypic information between relatives is disclosed, including receiving an indication that a first individual is a grandparent, receiving an indication that a second individual is a grandchild of the first individual, comparing the genotypic information of the first individual and the second individual and calculating a similarity score, and displaying an indication of the similarity score graphically using colors.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: November 9, 2021
    Assignee: 23andMe, Inc.
    Inventors: Linda Avey, Oleksiy Khomenko, Brian Thomas Naughton, Serge Saxonov, Anne Wojcicki, Alexander Wong
  • Patent number: 11171962
    Abstract: Sharing data is disclosed. In some cases, sharing data includes receiving a request to share data from a first account to a second account, receiving an indication of a plurality of first account profiles associated with the first account to share with the second account, and establishing sharing from the plurality of first account profiles to the second account, wherein sharing comprises the second account having read access to a subset of nonpublic data associated with the plurality of first account profiles.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: November 9, 2021
    Assignee: 23andMe, Inc.
    Inventors: Brian Lee Hawthorne, Oleksiy Khomenko, Jeffrey Mellen, Marcela Miyazawa, Michael Polcari, Jack Tihon, Alexander Wong, Anne Wojcicki, Linda Avey
  • Patent number: 11168140
    Abstract: The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human interleukin-1 receptor accessory protein (hu-IL1RAP) and fully block the IL-1, IL-33, and IL-36 intracellular signaling pathways. Compositions comprising such binding proteins and methods of making and using such binding proteins are also provided.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: November 9, 2021
    Assignee: 23andMe, Inc.
    Inventors: Davide Foletti, Erik Karrer, Germaine Fuh-Kelly, Kristie Ibarra, Quan Zheng, Yao-ming Huang, Lindsay Deis, Christine Wolak, Dominic Samuel Berns
  • Patent number: D943622
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: February 15, 2022
    Assignee: 23andMe, Inc.
    Inventors: Peilun Shan, Jie Wei, Magdalene Misztal, Brad Kittredge, Caitlyn Elizabeth Adams, Afton Kerry Vechery, Vilia Ingriany, Timmy Chau, Claudio Guglieri Lillo, Sampo Aleksi Jalasto, Joel Parsons, Jesse Jouni Sakari Maula
  • Patent number: D954107
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: June 7, 2022
    Assignee: 23andMe, Inc.
    Inventors: Tracy Keim, Sooyun Choi, Sampo Aleksi Jalasto, Joel Parsons, Jesse Jouni Sakari Maula
  • Patent number: D955427
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: June 21, 2022
    Assignee: 23andMe, Inc.
    Inventors: Peilun Shan, Jie Wei, Magdalene Misztal, Brad Kittredge, Caitlyn Elizabeth Adams, Afton Kerry Vechery, Vilia Ingriany, Timmy Chau, Claudio Guglieri Lillo, Sampo Aleksi Jalasto, Joel Parsons, Jesse Jouni Sakari Maula
  • Patent number: D969156
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: November 8, 2022
    Assignee: 23andMe, Inc.
    Inventors: Peilun Shan, Jie Wei, Magdalene Misztal, Brad Kittredge, Caitlyn Elizabeth Adams, Afton Kerry Vechery, Vilia Ingriany, Timmy Chau, Claudio Guglieri Lillo, Sampo Aleksi Jalasto, Joel Parsons, Jesse Jouni Sakari Maula